TrialBritish journal of haematology2018

Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.

Lihua E Budde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.